Abstract
There is evidence that serotonin and norepinephrine are in some way involved in the pathophysiology of anxiety disorders. Urinary levels of the serotonin metabolite 5-hydroxyindoleacetic acid (5-HIAA) and the norepinephrine metabolite vanillylmandelic acid (VMA) were measured in 46 patients with generalized anxiety disorder. There was a significant association between urinary levels of 5-HIAA and VMA: r = 0.79; p = 0.0001. Possible implications of this finding are discussed.
| Original language | English |
|---|---|
| Pages (from-to) | 6-9 |
| Number of pages | 4 |
| Journal | Neuropsychobiology |
| Volume | 31 |
| Issue number | 1 |
| DOIs | |
| State | Published - 1995 |
Keywords
- 5-Hydroxyindoleacetic acid
- Generalized anxiety disorder
- Vanillylmandelic acid
